Results of the Intergroup Rhabdomyosarcoma Study Group D9602 Protocol, Using Vincristine and Dactinomycin With or Without Cyclophosphamide and Radiation Therapy, for Newly Diagnosed Patients With Low-Risk Embryonal Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group

PURPOSE: Patients with localized, grossly resected, or gross residual (orbital only) embryonal rhabdomyosarcoma (ERMS) had 5-year failure-free survival (FFS) rates of 83% and overall survival rates of 95% on Intergroup Rhabdomyosarcoma Study Group (IRSG) protocols III/IV. IRSG D9602 protocol (1997 t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Beverly Raney, R., Walterhouse, David O., Meza, Jane L., Andrassy, Richard J., Breneman, John C., Crist, William M., Maurer, Harold M., Meyer, William H., Parham, David M., Anderson, James R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2011
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3083999/
https://ncbi.nlm.nih.gov/pubmed/21357783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.30.4469
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados